88
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection

, , , , , , , , & show all
Pages 6765-6774 | Published online: 19 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Millie Das, Sarika Ogale, Nick Jovanoski, Ann Johnson, Caroline Nguyen, Jan Bhagwakar & Janet S Lee. (2023) Cost–effectiveness of Adjuvant Atezolizumab for Patients with Stage II–IIIA PD-L1+ Non-Small-Cell Lung Cancer. Immunotherapy 15:8, pages 573-581.
Read now

Articles from other publishers (11)

Yutaro Koike, Keiju Aokage, Masashi Wakabayashi, Takashi Ikeno, Ken Onodera, Joji Samejima, Tomohiro Miyoshi, Kenta Tane, Kenji Suzuki & Masahiro Tsuboi. (2024) Long-term outcomes of 5-year survivors without recurrence after the complete resection of non-small cell lung cancer after lobectomy: a landmark analysis in consideration of competing risks. Surgery Today.
Crossref
Jamila Mammadova & Tawee Tanvetyanon. (2023) Association Between ALK Rearrangement and Ultra-Late Recurrence in Lung Cancer: Case Report and Pooled Analysis. Cureus.
Crossref
Jianhua Zhou, Zhiguo Ren, Xiwen Gao & Xiaohui Zhou. (2023) Surgical site wound infection and wound pain after video‐assisted thoracoscopy in patients with lung cancer: A meta‐analysis. International Wound Journal 20:9, pages 3898-3905.
Crossref
A. Razzaque Ahmed, Mikole Kalesinskas & Sarah Kooper-Johnson. (2023) Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype. Autoimmunity Reviews 22:10, pages 103444.
Crossref
Ha-Young Park, Joo-Heon Park, Myung-Geun Shin, Seung Jung Han, Yong-Sok Ji, Hyung-Joo Oh, Young-Chul Kim, Taebum Lee, Yoo-Duk Choi & In-Jae Oh. (2023) Case Report: A case of ultra-late recurrence of KIF13A-RET fusion non-small cell lung cancer response to selpercatinib. Frontiers in Oncology 13.
Crossref
David Smith, Micaela Raices, Federico Cayol, Franco Corvatta, Lucas Caram & Agustín Dietrich. (2022) Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?. Seminars in Oncology 49:6, pages 482-489.
Crossref
Xiaoqing Fan, Shaolin Tao, Qing Li, Bo Deng, Qun-You Tan & Hua Jin. (2022) The miR-23a/27a/24-2 cluster promotes postoperative progression of early-stage non-small cell lung cancer. Molecular Therapy - Oncolytics 24, pages 205-217.
Crossref
Raices Micaela, Caram Lucas, Corvatta Franco, Cayol Federico, Dietrich Agustín & Smith David. (2021) Dynamic perioperative variation of neutrophil-to-lymphocyte ratio as an independent prognosis factor following lobectomy for NSCLC. Updates in Surgery 73:4, pages 1567-1574.
Crossref
Jung Eun Yoo, Kyungdo Han, Dong Wook Shin, Sang Hyun Park, In Young Cho, Dong Woog Yoon, Jongho Cho & Kyu‐Won Jung. (2020) Conditional relative survival and competing mortality in patients who underwent surgery for lung cancer: A nationwide cohort study. International Journal of Cancer 148:3, pages 626-636.
Crossref
Shohei Matsuo, Yoshitane Tsukamoto, Eiichiro Mabuchi, Shunichi Negoro & Seiichi Hirota. (2020) A case of late distant recurrence/metastasis (≧10 years after curative surgery) of anaplastic lymphoma kinase-rearranged lung cancer and the review of similar cases in the literature. Human Pathology: Case Reports 22, pages 200421.
Crossref
Hongjun Fei, Songchang Chen & Chenming Xu. (2020) Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma. BioMed Research International 2020, pages 1-18.
Crossref